Filing Details
- Accession Number:
- 0000885590-11-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-07 15:55:11
- Reporting Period:
- 2011-12-05
- Filing Date:
- 2011-12-07
- Accepted Time:
- 2011-12-07 15:55:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1536053 | Bradley Howard Schiller | 7150 Mississauga Road Mississauga A6 L5N 8M5 | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2011-12-05 | 11,000 | $46.82 | 43,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. Purchases were made in the range of $46.13 to $47.32.
- This number includes 32,500 common shares purchased by the officer that were previously reported in Table 1.